These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 2681518)

  • 1. Effects of the neutrophil-activating peptide NAP-2, platelet basic protein, connective tissue-activating peptide III and platelet factor 4 on human neutrophils.
    Walz A; Dewald B; von Tscharner V; Baggiolini M
    J Exp Med; 1989 Nov; 170(5):1745-50. PubMed ID: 2681518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formation of neutrophil-activating peptide 2 from platelet-derived connective-tissue-activating peptide III by different tissue proteinases.
    Car BD; Baggiolini M; Walz A
    Biochem J; 1991 May; 275 ( Pt 3)(Pt 3):581-4. PubMed ID: 2039437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure and bioactivity of recombinant human CTAP-III and NAP-2.
    Proudfoot AE; Peitsch MC; Power CA; Allet B; Mermod JJ; Bacon K; Wells TN
    J Protein Chem; 1997 Jan; 16(1):37-49. PubMed ID: 9055206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of the neutrophil-activating peptide NAP-2 from platelet basic protein or connective tissue-activating peptide III through monocyte proteases.
    Walz A; Baggiolini M
    J Exp Med; 1990 Feb; 171(2):449-54. PubMed ID: 2406364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotactic activity and receptor binding of neutrophil attractant/activation protein-1 (NAP-1) and structurally related host defense cytokines: interaction of NAP-2 with the NAP-1 receptor.
    Leonard EJ; Yoshimura T; Rot A; Noer K; Walz A; Baggiolini M; Walz DA; Goetzl EJ; Castor CW
    J Leukoc Biol; 1991 Mar; 49(3):258-65. PubMed ID: 1997632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of neutrophil functions by the ELR(+) CXC chemokine platelet basic protein.
    Ehlert JE; Ludwig A; Grimm TA; Lindner B; Flad HD; Brandt E
    Blood; 2000 Nov; 96(9):2965-72. PubMed ID: 11049972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural requirements of platelet chemokines for neutrophil activation.
    Yan Z; Zhang J; Holt JC; Stewart GJ; Niewiarowski S; Poncz M
    Blood; 1994 Oct; 84(7):2329-39. PubMed ID: 7919350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombin-activated human platelets release two NAP-2 variants that stimulate polymorphonuclear leukocytes.
    Piccardoni P; Evangelista V; Piccoli A; de Gaetano G; Walz A; Cerletti C
    Thromb Haemost; 1996 Nov; 76(5):780-5. PubMed ID: 8950790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of human basophils through the IL-8 receptor.
    Krieger M; Brunner T; Bischoff SC; von Tscharner V; Walz A; Moser B; Baggiolini M; Dahinden CA
    J Immunol; 1992 Oct; 149(8):2662-7. PubMed ID: 1383321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Connective tissue-activating peptide III desensitizes chemokine receptors on neutrophils. Requirement for proteolytic formation of the neutrophil-activating peptide 2.
    Härter L; Petersen F; Flad HD; Brandt E
    J Immunol; 1994 Dec; 153(12):5698-708. PubMed ID: 7989767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The amino-terminal residues in the crystal structure of connective tissue activating peptide-III (des10) block the ELR chemotactic sequence.
    Malkowski MG; Lazar JB; Johnson PH; Edwards BF
    J Mol Biol; 1997 Feb; 266(2):367-80. PubMed ID: 9047370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophils can generate their activator neutrophil-activating peptide 2 by proteolytic cleavage of platelet-derived connective tissue-activating peptide III.
    Brandt E; Van Damme J; Flad HD
    Cytokine; 1991 Jul; 3(4):311-21. PubMed ID: 1873479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular cloning and characterisation of a neutrophil chemotactic protein from porcine platelets.
    Power CA; Proudfoot AE; Magnenat E; Bacon KB; Wells TN
    Eur J Biochem; 1994 Apr; 221(2):713-9. PubMed ID: 7513641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The neutrophil-activating proteins interleukin 8 and beta-thromboglobulin: in vitro and in vivo comparison of NH2-terminally processed forms.
    Van Damme J; Rampart M; Conings R; Decock B; Van Osselaer N; Willems J; Billiau A
    Eur J Immunol; 1990 Sep; 20(9):2113-8. PubMed ID: 2145175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Connective tissue-activating peptide-III and its derivative, neutrophil-activating peptide-2, release histamine from human basophils.
    Reddigari SR; Kuna P; Miragliotta GF; Kornfeld D; Baeza ML; Castor CW; Kaplan AP
    J Allergy Clin Immunol; 1992 Mar; 89(3):666-72. PubMed ID: 1372016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXC chemokines connective tissue activating peptide-III and neutrophil activating peptide-2 are heparin/heparan sulfate-degrading enzymes.
    Hoogewerf AJ; Leone JW; Reardon IM; Howe WJ; Asa D; Heinrikson RL; Ledbetter SR
    J Biol Chem; 1995 Feb; 270(7):3268-77. PubMed ID: 7852412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The beta-thromboglobulins and platelet factor 4: blood platelet-derived CXC chemokines with divergent roles in early neutrophil regulation.
    Brandt E; Petersen F; Ludwig A; Ehlert JE; Bock L; Flad HD
    J Leukoc Biol; 2000 Apr; 67(4):471-8. PubMed ID: 10770278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil-activating properties of the melanoma growth-stimulatory activity.
    Moser B; Clark-Lewis I; Zwahlen R; Baggiolini M
    J Exp Med; 1990 May; 171(5):1797-802. PubMed ID: 2185333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased microvascular permeability in vivo in response to intradermal injection of neutrophil-activating protein (NAP-2) in rabbit skin.
    Van Osselaer N; Van Damme J; Rampart M; Herman AG
    Am J Pathol; 1991 Jan; 138(1):23-7. PubMed ID: 1824807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation, characterization, and immunological detection of neutrophil-activating peptide 2: a proteolytic degradation product of platelet basic protein.
    Holt JC; Yan ZQ; Lu WQ; Stewart GJ; Niewiarowski S
    Proc Soc Exp Biol Med; 1992 Feb; 199(2):171-7. PubMed ID: 1531540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.